Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2008 13:01 ET | Source: Lakefront Biotherapeutics

Galapagos NV: Director/PDMR Shareholding

Galapagos NV ("the Company") 25 March 2008 Pursuant to Rule 17 of the AiM rules for companies, Galapagos discloses that Onno van de Stolpe, a member of the Executive Committee and...
January 25, 2008 02:00 ET | Source: Lakefront Biotherapeutics

Galapagos ontvangt €3,4 miljoen succesbetaling uit alliantie met Janssen Pharmaceutica NV

Mechelen, België, 25 januari 2008 - Galapagos NV (Euronext & LSE: GLPG) kondigt aan dat zij een mijlpaal heeft bereikt in de overeenkomst met Janssen Pharmaceutica NV ("Janssen") op gebied van...
January 25, 2008 02:00 ET | Source: Lakefront Biotherapeutics

Galapagos achieves €3.4 million milestone payment from Janssen Pharmaceutica NV

Mechelen, Belgium; 25 January 2008 - Galapagos NV (Euronext & LSE: GLPG) announced today achievement of a milestone under its alliance agreement in rheumatoid arthritis with Janssen Pharmaceutica...
November 12, 2007 10:20 ET | Source: Orexo AB

Orexo acquires Biolipox - Update regarding revised transaction structure and proposal regarding election of chairman and members of the board of directors for the Extraordinary General Meeting on November 13, 2007

Orexo acquires Biolipox - Update regarding revised transaction structure and proposal regarding election of chairman and members of the board of directors for the Extraordinary General Meeting on...
November 12, 2007 10:20 ET | Source: Orexo AB

Orexo förvärvar Biolipox - Uppdatering angående reviderad transaktionsstruktur samt förslag till val av styrelseordförande och styrelseledamöter inför extra bolagstämma den 13 november 2007

Orexo förvärvar Biolipox - Uppdatering angående reviderad transaktionsstruktur samt förslag till val av styrelseordförande och styrelseledamöter inför extra bolagstämma den 13 november 2007 Som...
March 08, 2007 02:00 ET | Source: Lakefront Biotherapeutics

Galapagos gaat chemische molecuulcollecties leveren aan Johnson & Johnson Pharmaceutical Research & Development Divisie van Janssen Pharmaceutica NV

Mechelen, België - Galapagos NV (Euronext & LSE: GLPG) kondigt vandaag aan dat haar service divisie, BioFocus DPI, een overeenkomst heeft afgesloten voor de levering van molecuulcollecties voor...
March 08, 2007 02:00 ET | Source: Lakefront Biotherapeutics

Galapagos to supply chemical compound sets to Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica NV

Mechelen, Belgium; 8 March 2007 - Galapagos NV (Euronext & LSE: GLPG) announced today that its service division, BioFocus DPI, has entered into an agreement to supply small molecule compounds for...
June 20, 2006 10:00 ET | Source: Lakefront Biotherapeutics

Galapagos NV ("Galapagos" or "Company") Annual Report and Accounts

Galapagos' Annual Report and Accounts for the year ended 31 December 2005 has been posted to shareholders and is available on the Company's website,...
November 24, 2005 02:12 ET | Source: Galapagos Genomics

Galapagos Enters Into Discovery Collaboration With Idenix for Infectious Disease Programs

MECHELEN, Belgium, Nov. 24, 2005 (PRIMEZONE) -- Galapagos NV (Euronext:GLPG) (LSE:GLPG) announced today that it has entered into a collaboration with Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) on...
November 10, 2005 02:26 ET | Source: Galapagos Genomics

Galapagos Announces Third Quarter 2005 Results

-- Acquisition of BioFocus completed, integration progresses as planned -- Galapagos year to date revenues 8% below last year's revenues, but cash burn in line with forecast --...